Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer
- PMID:16983741
- DOI: 10.1002/bjs.5506
Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer
Abstract
Background: Neoadjuvant chemoradiotherapy does not alter anal sphincter preservation or postoperative complications compared with short-course radiotherapy alone in patients with clinical stage T3 or T4 resectable rectal cancer. The aim of this study was to compare survival, local control and late toxicity in the two treatment groups.
Methods: The study randomized 312 patients to receive either preoperative irradiation (25 Gy in five fractions of 5 Gy) and surgery within 7 days or chemoradiation (50.4 Gy in 28 fractions of 1.8 Gy, bolus 5-fluorouracil and leucovorin) and surgery 4-6 weeks later. The median follow-up of living patients was 48 (range 31-69) months.
Results: Early radiation toxicity was higher in the chemoradiation group (18.2 versus 3.2 per cent; P < 0.001). The actuarial 4-year overall survival was 67.2 per cent in the short-course group and 66.2 per cent in the chemoradiation group (P = 0.960). Disease-free survival was 58.4 versus 55.6 per cent (P = 0.820), crude incidence of local recurrence was 9.0 versus 14.2 per cent (P = 0.170) and severe late toxicity was 10.1 versus 7.1 per cent (P = 0.360) respectively.
Conclusion: Neoadjuvant chemoradiation did not increase survival, local control or late toxicity compared with short-course radiotherapy alone.
Similar articles
- Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.Valentini V, Morganti AG, Gambacorta MA, Mohiuddin M, Doglietto GB, Coco C, De Paoli A, Rossi C, Di Russo A, Valvo F, Bolzicco G, Dalla Palma M; Study Group for Therapies of Rectal Malignancies (STORM).Valentini V, et al.Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1129-39. doi: 10.1016/j.ijrobp.2005.09.017. Epub 2006 Jan 18.Int J Radiat Oncol Biol Phys. 2006.PMID:16414206Clinical Trial.
- Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy.Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Pudełko M, Kryj M, Oledzki J, Szmeja J, Słuszniak J, Serkies K, Kładny J, Pamucka M, Kukołowicz P.Bujko K, et al.Radiother Oncol. 2004 Jul;72(1):15-24. doi: 10.1016/j.radonc.2003.12.006.Radiother Oncol. 2004.PMID:15236870Clinical Trial.
- Neoadjuvant chemoradiation versus hyperfractionated accelerated radiotherapy in locally advanced rectal cancer.Ceelen W, Boterberg T, Pattyn P, van Eijkeren M, Gillardin JM, Demetter P, Smeets P, Van Damme N, Monsaert E, Peeters M.Ceelen W, et al.Ann Surg Oncol. 2007 Feb;14(2):424-31. doi: 10.1245/s10434-006-9102-0. Epub 2006 Nov 10.Ann Surg Oncol. 2007.PMID:17096057
- Point: short-course radiation therapy is preferable in the neoadjuvant treatment of rectal cancer.Bujko K, Bujko M.Bujko K, et al.Semin Radiat Oncol. 2011 Jul;21(3):220-7. doi: 10.1016/j.semradonc.2011.02.008.Semin Radiat Oncol. 2011.PMID:21645867Review.
- Rectal cancer: Preoperative versus postoperative irradiation as a component of adjuvant treatment.Gunderson LL, Haddock MG, Schild SE.Gunderson LL, et al.Semin Radiat Oncol. 2003 Oct;13(4):419-32. doi: 10.1016/S1053-4296(03)00073-0.Semin Radiat Oncol. 2003.PMID:14586831Review.
Cited by
- Acute Radiation Colitis after Preoperative Short-Course Radiotherapy for Rectal Cancer: A Morphological, Immunohistochemical and Genetic Study.Zanelli M, Ciarrocchi A, De Petris G, Zizzo M, Costantini M, Bisagni A, Torricelli F, Nicoli D, Ramundo D, Ricci S, Palicelli A, Sanguedolce F, Ascani S, Castro Ruiz C, Annessi V, Zamponi R, Bortesi M, Martino V, Marchetti M, De Marco L.Zanelli M, et al.Cancers (Basel). 2020 Sep 9;12(9):2571. doi: 10.3390/cancers12092571.Cancers (Basel). 2020.PMID:32917028Free PMC article.
- Comparative Outcomes of Adenosquamous Carcinoma of the Gallbladder: an Analysis of the National Cancer Database.Murimwa G, Hester C, Mansour JC, Polanco PM, Porembka MR, Wang SC, Zeh HJ Jr, Yopp AC.Murimwa G, et al.J Gastrointest Surg. 2021 Jul;25(7):1815-1827. doi: 10.1007/s11605-020-04729-w. Epub 2020 Jul 23.J Gastrointest Surg. 2021.PMID:32705618
- Preoperative Ultrahypofractionated Radiation Therapy for Soft Tissue Sarcomas: Low Rate of Wound Complications.Mattmann A, Glanzmann C, Fuchs B, Bode B, Studer G; Swiss Sarcoma Network.Mattmann A, et al.Adv Radiat Oncol. 2024 Jul 23;9(10):101562. doi: 10.1016/j.adro.2024.101562. eCollection 2024 Oct.Adv Radiat Oncol. 2024.PMID:39314903Free PMC article.
- Randomized clinical trial on preoperative radiotherapy 25 Gy in rectal cancer--treatment results at 5-year follow-up.Pach R, Kulig J, Richter P, Gach T, Szura M, Kowalska T.Pach R, et al.Langenbecks Arch Surg. 2012 Jun;397(5):801-7. doi: 10.1007/s00423-011-0890-8. Epub 2011 Dec 15.Langenbecks Arch Surg. 2012.PMID:22170083Free PMC article.Clinical Trial.
- Radiotherapy for Colorectal Cancer: Current Standards and Future Perspectives.Häfner MF, Debus J.Häfner MF, et al.Visc Med. 2016 Jun;32(3):172-7. doi: 10.1159/000446486. Epub 2016 Jun 16.Visc Med. 2016.PMID:27493944Free PMC article.Review.
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources